Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105368913A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105368913A reveals dual-enzyme immobilization for chiral amino acids. Offers high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN105368913A reveals dual-enzyme immobilization for high-purity chiral unnatural amino acid production with significant cost and supply chain advantages.